Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008
Published online before print November 13, 2008, doi: 10.1161/CIRCRESAHA.108.184457
A more recent version of this article appeared on December 5, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
103/12/1466    most recent
CIRCRESAHA.108.184457v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terentyev, D.
Right arrow Articles by Györke, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terentyev, D.
Right arrow Articles by Györke, S.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Heart failure - basic studies

Submitted on February 24, 2008
Revised on September 29, 2008
Accepted on October 30, 2008

Redox Modification of Ryanodine Receptors Contributes to Sarcoplasmic Reticulum Ca2+ Leak in Chronic Heart Failure

Dmitry Terentyev ; Inna Györke ; Andriy E. Belevych ; Radmila Terentyeva ; Arun Sridhar ; Yoshinori Nishijima ; Esperanza Carcache de Blanco ; Savita Khanna ; Chandan K. Sen ; Arturo J. Cardounel ; Cynthia A. Carnes ; and Sandor Györke *

From the Departments of Physiology and Cell Biology (D.T., I.G., A.E.B., R.T., C.A.C., S.G.) and Surgery (S.K., C.K.S.), College of Medicine; and Department of Pharmacy and Biophysics (A.S., Y.N., E.C.d.B., C.A.C.), College of Pharmacy, Ohio State University, Columbus; and Department of Physiology (A.J.C.), College of Medicine, University of Florida, Tallahassee.

* To whom correspondence should be addressed. E-mail: Sandor.Gyorke{at}osumc.edu.

Abnormal cardiac ryanodine receptor (RyR2) function is recognized as an important factor in the pathogenesis of heart failure (HF). However, the specific molecular causes underlying RyR2 defects in HF remain poorly understood. In the present study, we used a canine model of chronic HF to test the hypothesis that the HF-related alterations in RyR2 function are caused by posttranslational modification by reactive oxygen species generated in the failing heart. Experimental approaches included imaging of cytosolic ([Ca2+]c) and sarcoplasmic reticulum (SR) luminal Ca2+ ([Ca2+]SR) in isolated intact and permeabilized ventricular myocytes and single RyR2 channel recording using the planar lipid bilayer technique. The ratio of reduced to oxidized glutathione, as well as the level of free thiols on RyR2 decreased markedly in failing versus control hearts consistent with increased oxidative stress in HF. RyR2-mediated SR Ca2+ leak measured directly as a time-dependent decline in [Ca2+]SR on blocking SR Ca2+ uptake was significantly enhanced in permeabilized myocytes, resulting in reduced [Ca2+]SR in HF compared to control cells. Both SR Ca2+ leak and [Ca2+]SR were partially normalized by treating HF myocytes with reducing agents. Conversely, oxidizing agents accelerated SR Ca2+ leak and decreased [Ca2+]SR in cells from normal hearts. Moreover, exposure to antioxidants significantly improved intracellular Ca2+-handling parameters in intact HF myocytes. Single RyR2 channel activity was significantly higher in HF versus control and was partially normalized by reducing agents, whereas oxidation of control RyR2s enhanced their activity reproducing the HF phenotype. These findings suggest that redox modification contributes to abnormal function of RyR2s in HF, presenting a potential therapeutic target for treating HF.


Key words: ryanodine receptor • heart failure • disulfide oxidation • Ca2+-induced Ca2+ release




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. D. Ullrich, M. Fanchaouy, K. Gusev, N. Shirokova, and E. Niggli
Hypersensitivity of excitation-contraction coupling in dystrophic cardiomyocytes
Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H1992 - H2003.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. R. Shannon
Ryanodine receptor Ca2+ sensitivity and excitation-contraction coupling in muscular dystrophy and heart failure: similar and yet different
Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H1965 - H1966.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. E. Belevych, D. Terentyev, S. Viatchenko-Karpinski, R. Terentyeva, A. Sridhar, Y. Nishijima, L. D. Wilson, A. J. Cardounel, K. R. Laurita, C. A. Carnes, et al.
Redox modification of ryanodine receptors underlies calcium alternans in a canine model of sudden cardiac death
Cardiovasc Res, December 1, 2009; 84(3): 387 - 395.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. L. Domeier, L. A. Blatter, and A. V. Zima
Alteration of sarcoplasmic reticulum Ca2+ release termination by ryanodine receptor sensitization and in heart failure
J. Physiol., November 1, 2009; 587(21): 5197 - 5209.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. R. Lyon, K. T. MacLeod, Y. Zhang, E. Garcia, G. K. Kanda, M. J. Lab, Y. E. Korchev, S. E. Harding, and J. Gorelik
Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart
PNAS, April 21, 2009; 106(16): 6854 - 6859.
[Abstract] [Full Text] [PDF]